Filing metadata

Accession number
0001104659-21-113876
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Sep 08, 2021
Reporting period
Sep 06, 2021
Description
Insider transaction

Explore SEC Filings Hub